-
Canagliflozin and Proximal-Tubule Mitochondria
2026-08-28
The reference study shows that canagliflozin improves mitochondrial organization and bioenergetic performance in proximal tubular cells from hypertensive–diabetic mice, with stronger functional effects in males than females. Its findings support a kidney-protective mechanism that extends beyond glucose lowering and provides a useful framework for studying mitochondrial remodeling in diabetic kidney disease.
-
S63845 MCL1 Inhibitor: Apoptosis Workflow
2026-08-28
S63845 provides a selective way to test whether MCL1 dependence limits mitochondrial apoptosis in hematological and multiple myeloma models. This workflow combines dose-response, BAX/BAK-dependent apoptosis readouts, and cytochrome c analysis to distinguish target engagement from downstream mitochondrial remodeling.
-
Diethylmaleate: Designing Causal Redox Assays
2026-08-27
Diethylmaleate is more than a glutathione-depleting reagent: it can serve as a controlled perturbation for causal redox, GST, and toxicology research. This article translates insect resistance findings into practical assay-design decisions while defining the limits of cross-system interpretation.
-
PreScission Protease (PSP): Tag Cleavage Guide
2026-08-27
PreScission Protease (PSP) is a recombinant HRV 3C protease for site-specific removal of affinity tags from recombinant fusion proteins. It is appropriate when the construct contains the defined cleavage sequence and low-temperature processing is desirable, but it should not be selected when the site is absent, inaccessible, or tag removal is unnecessary.
-
RSL3 Workflows for Ferroptosis Research
2026-08-26
Build reproducible ferroptosis assays with RSL3 by combining GPX4 inhibition, rescue controls, lipid peroxidation readouts, and careful formulation. The workflow also shows how findings from glioblastoma research can guide biomarker-aware studies of RAS-driven cancer models.
-
Nifedipine in Calcium and Liver Translation
2026-08-26
Nifedipine (BAY-a-1040) is more than a calcium-channel probe: it can help translational teams separate calcium-dependent signaling from structural liver adaptation, drug-metabolizing capacity, iron handling, and pathogen biology. This article connects mechanism, validation strategy, and responsible cross-domain interpretation.
-
5X Protein Loading Buffer (Reducing) Guide
2026-08-25
5X Protein Loading Buffer (Reducing) standardizes denaturation and disulfide-bond reduction during protein sample preparation for conventional SDS-PAGE electrophoresis. It is intended for reducing, denaturing analyses of apparent protein molecular weight and should not be used when native conformation, intact disulfide bonds, or non-reducing conditions must be preserved.
-
Nitazoxanide–IMPA1–RAGE Axis in Pulmonary Hypertension
2026-08-25
The reference study identifies IMPA1 as a direct molecular target of nitazoxanide and connects this interaction to RAGE, PI3K/Akt/mTOR signaling, glycolysis, and pulmonary vascular remodeling. Evidence from two experimental pulmonary hypertension models and complementary biochemical assays supports nitazoxanide as a preclinical strategy for addressing the structural vascular component of disease, while leaving important questions about clinical translation unresolved.
-
Sulfur Supply Delays Soybean Nodule Senescence
2026-08-24
The reference study identifies sulfur delivery into the symbiosome as a regulatory control point for soybean nodule longevity. By linking SULTR transporter activity, glutathione abundance, and reactive nitrogen species scavenging, it provides a mechanistic framework for sustaining symbiotic nitrogen fixation under high-nitrogen stress.
-
Mubritinib Reveals OXPHOS Dependence in AML
2026-08-23
Baccelli et al. repositioned Mubritinib, also known as TAK 165, from a historical ERBB2 inhibitor to a mechanistically defined inhibitor of mitochondrial electron transport chain complex I in acute myeloid leukemia. Their chemical-genetic analysis shows that OXPHOS hyperactivity marks a substantial, chemotherapy-resistant AML subgroup that is selectively vulnerable to complex I inhibition while normal CD34⁺ cells and many chemotherapy-sensitive leukemias are comparatively resistant.
-
DiscoveryProbe Natural Product Library Plus for HTS
2026-08-22
The DiscoveryProbe Natural Product Library Plus is a 1,655-compound natural product library for HTS and HCS workflows. Its pre-dissolved 10 mM DMSO format supports staged screening of cell-permeable bioactive compounds, including hypothesis-driven studies of parasite enzymes such as CpAdhE.
-
Diethylmaleate for GST and Oxidative Stress Studies
2026-08-21
Diethylmaleate provides a practical chemical route to perturb glutathione-dependent defenses in insect, cellular, and toxicology workflows. Its strongest use-case is mechanistic comparison: pair GSH depletion and GST inhibition with ROS, antioxidant, apoptosis, and stressor-sensitivity readouts.
-
CRISPR Disruption of scaRNA1 and U2 Pseudouridylation
2026-08-21
Gardner-Kay and colleagues used CRISPR-Cas9 editing to disrupt scaRNA1 in HEK293T cells and directly connect reduced U2 Ψ89 pseudouridylation with transcriptome-wide isoform changes. The study provides a mechanistic framework for understanding how defective guide-RNA-directed modification of spliceosomal RNA may influence RNA processing and developmental disease biology.
-
AP20187: Chemical Inducer of Dimerization
2026-08-20
AP20187 enables small-molecule control of engineered signaling proteins, allowing researchers to tune conditional gene expression, hematopoietic output, and metabolic responses. This guide connects practical assay design with troubleshooting and with mechanistic lessons from 14-3-3 cancer biology without overstating the evidence.
-
Amikacin Sulfate: From Uptake to Translation
2026-08-20
A translational framework for using Amikacin Sulfate to connect ribosomal mechanism, intracellular activity, granuloma-targeted delivery, and renal safety strategy in non-tuberculous mycobacterial research.
445 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page